ACE2 Expression in the Airway Epithelium of Healthy Nonsmokers
In healthy (non-smoking) individuals, ACE2 — the cell-surface receptor SARS-CoV-2 uses to enter host cells — is expressed throughout the airway epithelium. Its expression in this baseline group has been characterized along three lines: (1) expression across the tracheobronchial tree (trachea, large airway epithelium, and small airway epithelium); (2) expression in primary basal cells as they differentiate; and (3) expression by individual cell type within the small airway epithelium. Together these establish the normal airway expression pattern used as a baseline for comparison with smokers and other conditions.
0
1
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
ACE2 Expression in the Small Airway Epithelium is Not Associated with Air Pollution in New York City
ACE2 Expression in the Airway Epithelium of Smokers
ACE2 Expression in the Airway Epithelium of Healthy Nonsmokers
Effects of COVID-19 on the Lungs
miR-1246 Levels May Modulate ACE2 Expression Levels in the Small Airway Epithelium
ACE2 and Other Cellular Proteins Related to B-Coronavirus Infection Expression Increases in Basal Cells from the Large Airway Epithelium Throughout Differentiation